Can a Daily Probiotic Ease Depression in Older Adults? What a New 2026 Trial Found

Reviewed by the HealthyMag Editorial Team. Last updated: July 2026. This is health information, not medical advice — for depression, work with a qualified professional.
Could a capsule of live bacteria help ease depression in later life? A new study published in June 2026 in the Journal of the American Geriatrics Society has renewed interest in that question — and, encouragingly, it approaches it with the caution the topic deserves. The trial, known as PRODG, tested whether adding a daily probiotic to standard antidepressant care could improve symptoms in older adults living with moderate depression.
The results were quietly promising rather than headline-shattering: the probiotic group did a little better than the placebo group on depression and anxiety measures. But the researchers themselves are the first to stress how small and preliminary this work is. Here is what the trial actually found, what the “gut–brain axis” really means, and — most importantly for anyone struggling with their mood — what it does and does not mean for you.
What the new 2026 trial found
The study, formally titled “Efficacy of Adjunct PRObiotics as Compared to the Standard Care in Moderate Unipolar Depression Among Geriatric Patients: A Randomized Double-Blind Placebo-Controlled Pilot Multi-Center Trial (PRODG),” was led by Preeti Sinha and colleagues and published in the Journal of the American Geriatrics Society (DOI 10.1111/jgs.70530).
Here are the key design details:
- Design: A randomized, double-blind, placebo-controlled, pilot, multi-center trial — the gold-standard format for reducing bias, though at a small scale.
- Participants: 58 adults aged 60 and older, all diagnosed with moderate unipolar depression.
- Groups: Participants were randomly assigned 1:1 to receive either a daily probiotic or an identical-looking placebo. Neither the patients nor the researchers knew who was getting what.
- Intervention: A daily probiotic containing the strains Lactobacillus helveticus and Bifidobacterium longum, taken alongside each person’s ongoing standard antidepressant treatment.
- Duration: 12 weeks of active treatment, followed by a further 12 weeks of follow-up monitoring.
Over the trial, the team tracked depression and anxiety using validated psychological rating scales. They also measured a biological marker in the blood — serum brain-derived neurotrophic factor (BDNF), a protein involved in the health and growth of nerve cells — and profiled participants’ gut bacteria through fecal samples.
The headline finding: adding the probiotic produced modest but meaningful reductions in depression and anxiety scores compared with adding a placebo. The probiotic group also showed changes in the biological and microbiome measures the researchers were watching. However — and this is a genuinely important caveat — the probiotic did not deliver a clear additional improvement in overall quality of life, and both groups improved substantially over the study. When even the placebo group gets meaningfully better, it becomes harder to be certain how much of the benefit truly came from the bacteria.
The gut-brain axis explained
Why would bacteria in your intestines have anything to do with your mood? The rationale comes from a well-established but still-evolving field of research called the gut–brain axis: a two-way communication network linking the gut and the central nervous system.
This “conversation” happens through several channels. The vagus nerve provides a direct nerve line between the gut and the brain. Gut bacteria also help produce and regulate signaling chemicals — including precursors to serotonin, the neurotransmitter most associated with mood — and they influence inflammation and the body’s stress-hormone system. The immune system and the metabolic byproducts of bacteria (such as short-chain fatty acids) add further layers to the crosstalk.
Because certain probiotic strains appear able to nudge this system, researchers have coined the term “psychobiotics” — live bacteria that, in adequate amounts, may produce a mental-health benefit. It is a compelling and biologically plausible idea. But plausible is not the same as proven. The honest scientific position is that the gut–brain axis is real and actively influences mood-related biology, yet translating that into a reliable, prescribable treatment for depression is still very much a work in progress.
What “adjunct” means and why it matters
The single most important word in the PRODG trial is adjunct. It means the probiotic was added to each participant’s existing antidepressant treatment — not used instead of it. Everyone in the study, in both the probiotic and placebo groups, continued receiving standard care throughout.
This matters enormously for how the results should be read. The trial did not test whether probiotics can treat depression on their own. It tested whether they might give a small extra boost on top of conventional treatment. So the takeaway is not “probiotics work for depression” — it is “in this pilot study, probiotics added to antidepressants appeared to help a little more than antidepressants plus a dummy pill.”
If you take away one thing from this article, make it this: a probiotic is not a substitute for professional depression treatment, and no one should stop or reduce a prescribed antidepressant based on this study. Stopping antidepressants abruptly can cause withdrawal effects and a return or worsening of symptoms, and should only ever be done gradually under medical supervision.
The bigger picture: what earlier evidence shows
PRODG did not arrive in a vacuum. It joins a growing but genuinely mixed body of research on probiotics and mood, and placing it in that context helps set realistic expectations.
On the encouraging side, a 2024 systematic review and meta-analysis in Nutrition Reviews pooled data from 23 randomized controlled trials covering 1,401 clinically diagnosed patients. It reported a large effect for probiotics in reducing depression scores (standardized mean difference of −0.96) and a moderate effect for anxiety (−0.59). Notably, prebiotics alone did not show a meaningful benefit for depression in the same analysis.
A more cautious picture comes from a 2026 umbrella review in Pharmaceuticals — essentially a review of reviews — titled “‘Attacking’ the Gut–Brain Axis with Psychobiotics.” It found that probiotics may confer a more moderate benefit for depressive symptoms (effect size around −0.50), but that results for anxiety were inconsistent, and that the wider evidence for prebiotics and synbiotics remains insufficient or heterogeneous. The authors flagged serious methodological limitations across the large majority of the reviews they examined.
In other words: there is a real signal that probiotics may help mood, but the size of that signal, which strains work best, and how durable the effect is all remain unsettled.
| Promising / supported by evidence | Unproven / still uncertain |
|---|---|
| Probiotics as an add-on to standard antidepressant care | Probiotics as a stand-alone or replacement treatment |
| Modest reductions in depression scores across several trials | The exact size and reliability of the benefit (estimates vary widely) |
| A biologically plausible gut–brain mechanism | Which specific strains and doses work best, and for whom |
| Generally good safety in healthy adults | Improvement in overall quality of life (no clear gain in PRODG) |
| Signal strong enough to justify larger trials | Long-term effects beyond a few months |
Which probiotics were used, and the honest limits
The PRODG trial used a combination of Lactobacillus helveticus and Bifidobacterium longum — two strains that appear frequently in psychobiotic research. It is worth noting that probiotic effects are considered strain-specific: results seen with one particular combination cannot be assumed to apply to every product on a store shelf that happens to say “Lactobacillus” or “Bifidobacterium” on the label.
And the limits of this trial are real. It was a pilot study of only 58 people, which is far too small to be definitive. It found no clear extra quality-of-life benefit, even where symptom scores improved — a reminder that lower numbers on a rating scale do not always translate into someone feeling meaningfully better in daily life. Both groups improved a lot, muddying the comparison. And the follow-up ran only 24 weeks in total, telling us nothing about long-term effects. The researchers explicitly called for larger studies before firm conclusions can be drawn. This is honest, careful science describing an early clue — not a breakthrough cure.
Food sources of probiotics
For most people, the everyday way to encounter beneficial bacteria is through fermented foods rather than a specific studied supplement. These foods have a long track record as part of a healthy diet and, for people who tolerate them, are a reasonable and low-risk addition to meals. Common options include:
- Yogurt and kefir with live and active cultures
- Sauerkraut and kimchi (unpasteurized, refrigerated versions retain live cultures)
- Miso and tempeh, made from fermented soybeans
- Kombucha, a fermented tea
- Traditional fermented pickles made in brine rather than vinegar
An important caveat: eating fermented foods is not the same as taking the precise strains and doses used in a clinical trial, and no one should expect a serving of yogurt to replicate the PRODG results — or to treat depression. Think of fermented foods as part of a broadly healthy, varied diet, alongside plenty of fiber-rich plants that feed your existing gut bacteria. A balanced diet supports overall wellbeing, and interest in nutrition and mood is not limited to the gut — we have explored related territory in our piece on vitamin C and your brain.
Who should be cautious
Probiotics are generally considered safe for healthy adults, but they are not risk-free for everyone. Talk to a doctor before starting a probiotic supplement if you:
- Have a weakened immune system, are undergoing chemotherapy, or take immunosuppressant medication
- Are seriously ill or hospitalized, or have a central venous catheter
- Have a history of certain gut conditions or recent major abdominal surgery
- Are managing depression — so any addition can be coordinated with your existing treatment plan
Older adults, the very population studied in PRODG, often take multiple medications and manage several health conditions at once, which is exactly why a professional should oversee any new supplement rather than adding it independently.
What to do
If you or someone you love is dealing with depression, the most evidence-based step is simple: talk to a qualified health professional. Depression is a serious, treatable medical condition, and effective options — including therapy, medication, and lifestyle support — already exist and are backed by far stronger evidence than any probiotic to date.
If you are curious about probiotics as a possible add-on, raise it with your doctor rather than experimenting alone. They can help you weigh it against your current treatment, other medications, and health conditions. And under no circumstances should you stop, skip, or reduce a prescribed antidepressant on your own based on a single pilot study. If you are in crisis or having thoughts of harming yourself, contact your local emergency services or a suicide-prevention helpline right away.
Frequently Asked Questions
Can probiotics help with depression?
The current evidence suggests probiotics may offer a modest benefit for depressive symptoms, mainly when used as an add-on to standard treatment. The 2026 PRODG pilot trial found small extra reductions in depression scores among older adults who added a probiotic to their antidepressants, and some meta-analyses report positive effects. But the evidence is mixed and the studies are often small, so probiotics are not an established or proven treatment for depression on their own.
What is the gut-brain axis?
The gut–brain axis is the two-way communication network between your digestive system and your brain. It works through the vagus nerve, immune signaling, hormones, and chemicals produced by gut bacteria — some of which are linked to mood-regulating neurotransmitters like serotonin. This connection is why researchers study whether changing gut bacteria could influence mental health.
Which probiotics are best for mood?
There is no definitive “best” probiotic for mood, because effects are strain-specific and the research is still early. The PRODG trial used a combination of Lactobacillus helveticus and Bifidobacterium longum, two strains commonly studied in this area. However, results from one specific product cannot be assumed to apply to all probiotic supplements. A doctor is the best source of advice for your situation.
Can probiotics replace antidepressants?
No. In every relevant trial, including PRODG, probiotics were tested as an adjunct — added to standard antidepressant care, not used in place of it. There is no good evidence that probiotics can replace prescribed antidepressants, and you should never stop or reduce a prescribed medication based on probiotic research. Any change to antidepressant treatment should be made gradually and only under medical supervision.
How long do probiotics take to affect mood?
In clinical trials, benefits for mood are typically assessed over several weeks — commonly 8 to 12 weeks, and the PRODG trial ran for 12 weeks of active treatment. There is no reliable evidence of rapid, day-to-day mood changes from probiotics, and effects, where they occur, appear gradual and modest rather than immediate.
Are fermented foods as good as probiotic supplements?
Not necessarily in the same way. Fermented foods like yogurt, kefir, kimchi, and sauerkraut contain live cultures and are a healthy addition to most diets, but they do not deliver the specific strains and measured doses used in clinical trials. Eating fermented foods is a reasonable part of a balanced diet, but it should not be viewed as a treatment for depression or a substitute for the studied products.
Are probiotics safe?
For most healthy adults, probiotics are generally considered safe and side effects are usually mild, such as temporary bloating or gas. However, they are not risk-free for everyone. People with weakened immune systems, serious illness, or certain medical conditions should talk to a doctor first. Anyone managing depression should coordinate any new supplement with the professional overseeing their care.
The Bottom Line
The 2026 PRODG trial adds a genuine, carefully collected clue to the story of the gut–brain axis: in older adults with moderate depression, adding a daily probiotic to standard antidepressant treatment produced modest extra improvements in depression and anxiety scores over 12 weeks. That is worth paying attention to — but it is a small, early, pilot-scale finding, the probiotic was an add-on rather than a replacement, both groups improved substantially, and there was no clear gain in overall quality of life. Larger trials are needed before anyone can call probiotics a treatment for depression.
The responsible takeaway is one of cautious interest, not hype. If you are living with depression, the strongest, best-established help comes from working with a qualified professional. A probiotic — or a serving of yogurt — is at most a possible complement to that care, and never a reason to change or stop a prescribed medication on your own.
Sources
- Sinha P, Chatterjee P, Kathiresan P, et al. “Efficacy of Adjunct PRObiotics as Compared to the Standard Care in Moderate Unipolar Depression Among Geriatric Patients: A Randomized Double-Blind Placebo-Controlled Pilot Multi-Center Trial (PRODG).” Journal of the American Geriatrics Society, 2026. DOI: 10.1111/jgs.70530. https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.70530
- “Effects of Prebiotics and Probiotics on Symptoms of Depression and Anxiety in Clinically Diagnosed Samples: Systematic Review and Meta-analysis of Randomized Controlled Trials.” Nutrition Reviews, 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC12166186/
- “‘Attacking’ the Gut–Brain Axis with Psychobiotics: An Umbrella Review of Depressive and Anxiety Symptoms.” Pharmaceuticals (Basel), 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12845323/


